Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in ANRO — Alto Neuroscience, Inc.

CIK 1549230 NEW YORK, NY
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,803,515
-$328,038 QoQ
Shares Held
106,234
-23.7% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#35
of 114 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Derivatives in ANRO

reported options exposure · as of Sep 30, 2024
CallValue
$1,441,440
CallShares
126,000
PutValue
$1,505,504
PutShares
131,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. ANRO ranks #53 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in ANRO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,803,515 106,234
2026-03-31 $3,131,553 139,304
2025-12-31 $2,479,611 139,304
2025-09-30 $130,537 32,472
2025-06-30 $71,438 32,472
2025-03-31 $121,245 56,132
2024-12-31 $436,113 103,100
2024-09-30 $1,505,504 131,600
2024-09-30 $1,441,440 126,000